These 'Covid stocks' defy the standard definition

Investors have been enamored of 'coronavirus stocks' since the pandemic began, focusing on the biotechs, pharmaceuticals and technology companies benefitting from the trouble. But Noland Langford, chief executive at Left Brain Investment Research, now has his eyes on a different style of Covid play, the kind of company in varied businesses that will benefit as an unforeseen offshoot of the global health care crisis. Here, he identifies three such stocks, one each in real estate, exercise equipment and gambling.